Kathleen Scott - 29 Nov 2022 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role
Chief Financial Officer
Signature
/s/ Kathleen Scott
Issuer symbol
SPRY
Transactions as of
29 Nov 2022
Transactions value $
$51,506
Form type
4
Filing time
01 Dec 2022, 15:31:51 UTC
Previous filing
10 Nov 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRY Common Stock Purchase $51,506 +8,250 $6.24 8,250 29 Nov 2022 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $6.16 to $6.26, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 By Scott 2008 Trust Dated 3/28/08.